Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1694954

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1694954

Sanger Sequencing Global Market Report 2025

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 4490
PDF (Site License)
USD 6490
PDF (Enterprise License)
USD 8490

Add to Cart

Sanger sequencing, also known as chain termination sequencing, is a technique utilized to determine the nucleotide sequence of DNA. It finds application in smaller-scale projects and validating the results of deep sequencing, producing DNA sequence reads exceeding 500 nucleotides while maintaining high accuracy levels.

Sanger sequencing encompasses several types, including shotgun sequencing, targeted gene sequencing, and others. In shotgun sequencing, random fragments of a lengthy DNA molecule are sequenced in parallel and then pieced together using their overlapping segments. Laboratories employing Sanger sequencing methods can be categorized as wet labs or dry labs, while research endeavors can be conducted in-house or outsourced. These techniques are employed across various applications such as diagnostics, biomarkers, cancer research, reproductive health, personalized medicine, forensics, among others. Moreover, Sanger sequencing serves a diverse range of end-users including academic institutions, government research institutes, pharmaceutical companies, biotechnology firms, hospitals, and clinics.

The sanger sequencing market research report is one of a series of new reports from The Business Research Company that provides sanger sequencing market statistics, including sanger sequencing industry global market size, regional shares, competitors with a sanger sequencing market share, detailed sanger sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the sanger sequencing industry. This sanger sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sanger sequencing market size has grown rapidly in recent years. It will grow from $2.75 billion in 2024 to $3.3 billion in 2025 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to increased research demand, increasing medical diagnostics, increased pharmaceutical development, increased agricultural applications, increased forensic analysis, increased biomarker discovery, increased genetic evolution studies.

The sanger sequencing market size is expected to see rapid growth in the next few years. It will grow to $6.17 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to increasing clinical genomics integration, expanded agricultural genomics, increasing drug safety and pharmacogenomics, increasing prenatal and newborn screening, increasing environmental DNA analysis. Major trends in the forecast period include technological advancements, growing demand for next-generation sequencing, increasing applications in clinical diagnostics, rising investments in genomics research, expanding use in personalized medicine.

The increase in genetic illnesses is expected to drive the growth of the Sanger sequencing market in the coming years. Genetic illnesses, or genetic disorders, are medical conditions caused by abnormalities or mutations in an individual's DNA, the hereditary material that carries genetic information. Sanger sequencing is a method used to diagnose these disorders by determining the precise order of nucleotides (the building blocks of DNA) in a specific gene or DNA region. For example, in August 2024, the National Health Service, a UK-based publicly funded healthcare organization, reported that around 2,300 people in the UK are living with thalassemia, with approximately 800 individuals affected by the severe form of the condition who rely on regular blood transfusions. Thus, the rise in genetic illnesses is fueling the growth of the Sanger sequencing market.

Leading companies in the Sanger sequencing market are focusing on expanding genomic laboratories to offer rapid Sanger sequencing services in the northern UK. Genomic laboratories are specialized facilities for conducting genetic testing and analysis, aimed at studying the structure, function, and inheritance of genes and genomes for purposes such as diagnosis, research, and personalized medicine. In June 2023, for instance, Source Genomics, a UK-based provider of genomic services, announced the expansion of their genomic laboratory to the north of the UK, which will increase their capacity for Sanger sequencing services and reduce data turnaround times. This geographic expansion represents a significant step in providing equitable access to genomic services across the UK, enabling research organizations nationwide to benefit from high-quality Sanger sequencing services with faster turnaround times.

In January 2023, Qiagen, a German company specializing in sample and assay technologies, acquired Verogen for $150 million. This strategic move enables Qiagen to optimize its renowned sample extraction and library preparation automation capabilities, thereby bolstering the channel reach and market presence of both companies in support of the forensic market. Verogen, based in the United States, is a leading provider of Sanger sequencing solutions tailored for human identification and forensic laboratories.

Major companies operating in the sanger sequencing market report are Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty. Ltd., SciGenom Labs Pvt. Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies

North America was the largest region in the sanger sequencing market in 2024. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sanger sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sanger sequencing market includes revenues earned by entities by providing DNA synthesis, and targeted synthesis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sanger Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sanger sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sanger sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sanger sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Sequencing: Shotgun Sequencing; Targeted Gene Sequencing; Other Sequencing
  • 2) By Laboratory: Wet Labs; Dry Labs
  • 3) By Research: In-House; Outsourced
  • 4) By Application: Diagnostics; Biomarkers and Cancer; Reproductive Health; Personalized Medicine; Forensics; Other Applications
  • 5) By End User: Academic; Government Research Institutes; Pharmaceutical Companies; Biotechnology Companies; Hospitals; Clinics
  • Subsegments:
  • 1) By Shotgun Sequencing: Whole Genome Shotgun Sequencing; Metagenomic Shotgun Sequencing
  • 2) By Targeted Gene Sequencing: Amplicon Sequencing; Exome Sequencing
  • 3) By Other Sequencing: Nested PCR Sequencing; Sequencing By Synthesis (SBS)
  • Companies Mentioned: Hoffmann-La Roche; Thermo Fisher Scientific Inc.; Merck KGaA; Eurofins Scientific; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r28931

Table of Contents

1. Executive Summary

2. Sanger Sequencing Market Characteristics

3. Sanger Sequencing Market Trends And Strategies

4. Sanger Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Sanger Sequencing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Sanger Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Sanger Sequencing Market Growth Rate Analysis
  • 5.4. Global Sanger Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Sanger Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Sanger Sequencing Total Addressable Market (TAM)

6. Sanger Sequencing Market Segmentation

  • 6.1. Global Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Shotgun Sequencing
  • Targeted Gene Sequencing
  • Other Sequencing
  • 6.2. Global Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wet Labs
  • Dry Labs
  • 6.3. Global Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In-House
  • Outsourced
  • 6.4. Global Sanger Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics
  • Biomarkers and Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Other Applications
  • 6.5. Global Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic
  • Government Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Hospitals
  • Clinics
  • 6.6. Global Sanger Sequencing Market, Sub-Segmentation Of Shotgun Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Whole Genome Shotgun Sequencing
  • Metagenomic Shotgun Sequencing
  • 6.7. Global Sanger Sequencing Market, Sub-Segmentation Of Targeted Gene Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amplicon Sequencing
  • Exome Sequencing
  • 6.8. Global Sanger Sequencing Market, Sub-Segmentation Of Other Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nested PCR Sequencing
  • Sequencing By Synthesis (SBS)

7. Sanger Sequencing Market Regional And Country Analysis

  • 7.1. Global Sanger Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Sanger Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sanger Sequencing Market

  • 8.1. Asia-Pacific Sanger Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sanger Sequencing Market

  • 9.1. China Sanger Sequencing Market Overview
  • 9.2. China Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sanger Sequencing Market

  • 10.1. India Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sanger Sequencing Market

  • 11.1. Japan Sanger Sequencing Market Overview
  • 11.2. Japan Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sanger Sequencing Market

  • 12.1. Australia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sanger Sequencing Market

  • 13.1. Indonesia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sanger Sequencing Market

  • 14.1. South Korea Sanger Sequencing Market Overview
  • 14.2. South Korea Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sanger Sequencing Market

  • 15.1. Western Europe Sanger Sequencing Market Overview
  • 15.2. Western Europe Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sanger Sequencing Market

  • 16.1. UK Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sanger Sequencing Market

  • 17.1. Germany Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sanger Sequencing Market

  • 18.1. France Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sanger Sequencing Market

  • 19.1. Italy Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sanger Sequencing Market

  • 20.1. Spain Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sanger Sequencing Market

  • 21.1. Eastern Europe Sanger Sequencing Market Overview
  • 21.2. Eastern Europe Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sanger Sequencing Market

  • 22.1. Russia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sanger Sequencing Market

  • 23.1. North America Sanger Sequencing Market Overview
  • 23.2. North America Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sanger Sequencing Market

  • 24.1. USA Sanger Sequencing Market Overview
  • 24.2. USA Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sanger Sequencing Market

  • 25.1. Canada Sanger Sequencing Market Overview
  • 25.2. Canada Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sanger Sequencing Market

  • 26.1. South America Sanger Sequencing Market Overview
  • 26.2. South America Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sanger Sequencing Market

  • 27.1. Brazil Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sanger Sequencing Market

  • 28.1. Middle East Sanger Sequencing Market Overview
  • 28.2. Middle East Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sanger Sequencing Market

  • 29.1. Africa Sanger Sequencing Market Overview
  • 29.2. Africa Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sanger Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Sanger Sequencing Market Competitive Landscape
  • 30.2. Sanger Sequencing Market Company Profiles
    • 30.2.1. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Sanger Sequencing Market Other Major And Innovative Companies

  • 31.1. Beckman Coulter
  • 31.2. PerkinElmer Inc.
  • 31.3. BGI Group
  • 31.4. LGC Limited
  • 31.5. GenScript
  • 31.6. Oxford Nanopore Technologies
  • 31.7. Pacific Biosciences of California Inc.
  • 31.8. Macrogen Inc.
  • 31.9. GENEWIZ Inc.
  • 31.10. Quintara Biosciences
  • 31.11. CeMIA SA
  • 31.12. Source BioScience
  • 31.13. Microsynth AG
  • 31.14. Fasteris SA
  • 31.15. GenHunter Corporation

32. Global Sanger Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sanger Sequencing Market

34. Recent Developments In The Sanger Sequencing Market

35. Sanger Sequencing Market High Potential Countries, Segments and Strategies

  • 35.1 Sanger Sequencing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Sanger Sequencing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Sanger Sequencing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!